Remove Develop Remove Enterprise Partners Remove Venture Capital
article thumbnail

Enterprise Partners Re-Ups On Complete Genomics

socalTECH

San Diego-based venture capital firm Enterprise Partners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics , Complete Genomics said today. Complete Genomics is developing a DNA sequencing product which competes against products from Illumina.

article thumbnail

Q3 Southern California Venture Deals Around $879M

socalTECH

A quick analysis by socalTECH of our tracking of venture capital deals in Southern California finds that there was around $879M in venture funding activity here in Q3. The biggest are for venture activity in the quarter was Biopharmaceuticals, which was $299.13M of the quarterly total.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Breach Security Raises $5M More

socalTECH

Carlsbad-based Breach Security , a developer of IT security tools, announced this morning that it has raised $5M in additional funding, from existing investor Sid R. The firm said the expansion financing would go towards product development and further market expansion. 5, or Evergreen Venture Partners participated in this round.

article thumbnail

Opthonix Sees $5.39M More

socalTECH

Vista-based Opthonix , a developer of wavefront guided, high definition vision eyeglasses, has raised $5.39M as part of an ongoing, $12.1M Opthonix is venture backed by Cross Creek Capital, DAG Ventures, Enterprise Partners, Gund Investment Corp.,

article thumbnail

XIFIN Buys PathCentral

socalTECH

San Diego-based XIFIN , which develops cloud-based financial software for the healthcare industry, has acquired Irvine-based PathCentral , a developer of software for the pathology community, the company announced Thursday afternoon. XIFIN''s investors include Boulder Ventures, Enterprise Partners, and Windward Ventures.

Windward 138
article thumbnail

Celladon Gets $53M In Funding

socalTECH

San Diego-based Celladon , a biopharmaceuticals firm developing a genetically targeted enzyme replacement therapy which helps in the treatment of late-stage, heart failure, has raised $53M in a second close of a funding round, the firm said today. and Venrock. and Venrock. READ MORE>>.

Funding 145
article thumbnail

ParAccel Raises $22M

socalTECH

San Diego- and Cupertino-based ParAccel , a developer of software for massively parallel databases used for data warehousing analytics, announced today that it has raised $22M in a venture capital round. ParAccel said the funding will go towards product development, sales and marketing, and to ramp up services and support.